Last reviewed · How we verify
Malignant tumor of stomach
Approved treatments
- Carac · Spectrum Pharms
- Xeloda · Cheplapharm
Xeloda works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA synthesis in cancer cells. - Gimestat · Nordic Group BV
- Florafur · Nordic Group BV
- Eloxatin · Yakult Honsha
Oxaliplatin forms platinum-DNA crosslinks that inhibit replication and transcription. - Taxotere · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Docetaxol · Fudan University
- Carac · Extrovis
- Lonsurf · Taiho Oncology Inc
Lonsurf works by inhibiting the enzyme thymidine phosphorylase, which is involved in the breakdown of certain cancer medications. - Cyramza · Eli Lilly
Cyramza blocks the VEGFR2 receptor, which is involved in cancer cell growth and spread. - Opdivo · Bristol-Myers Squibb
Opdivo works by blocking the PD-1 receptor on immune cells, allowing them to attack cancer cells. - Taxotere · Sanofi
Taxotere works by binding to microtubules, preventing them from disassembling and thereby blocking cell division. - Fusilev · Spectrum Pharms
- Fusilev · Acrotech Biopharma
Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis. - Xeloda · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Clinical guidelines
- FDA label — not specified
Oxaliplatin Injection is indicated for the treatment of malignant tumor of the stomach, but specific details are not provided in the label. - FDA label — not specified
Oxaliplatin Injection is indicated for the treatment of metastasis from malignant tumor of the colon, but specific details are not provided in the label. - FDA label — not specified
Oxaliplatin Injection is indicated for the treatment of small intestine cancer, but specific details are not provided in the label. - FDA label — 1L
Docetaxel in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for advanced disease. - FDA label — 1L
Docetaxel in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of stomach patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of stomach treatment landscape brief
- Malignant tumor of stomach treatment updates RSS
Frequently asked questions about Malignant tumor of stomach
What drugs treat Malignant tumor of stomach?
Tracked treatments include Carac, Xeloda, Gimestat, Florafur, Eloxatin, Taxotere, Docetaxol, Lonsurf.
What is the treatment for Malignant tumor of stomach?
Standard treatment for Malignant tumor of stomach includes Carac, Xeloda, Gimestat, Florafur, Eloxatin. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Malignant tumor of stomach?
FDA label publishes guidelines for Malignant tumor of stomach. 5 guideline references tracked.
Related
- Treatment landscape: Malignant tumor of stomach patent cliff · Malignant tumor of stomach CI report
- Treatment: Carac · Spectrum Pharms
- Treatment: Xeloda · Cheplapharm
- Treatment: Gimestat · Nordic Group BV
- Treatment: Florafur · Nordic Group BV
- Treatment: Eloxatin · Yakult Honsha
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing